Endovascular Recanalization Methods in Treatment of Chronic Lower Limb Ischemia: Modern State of Problem

Cover Page


Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription or Fee Access

Abstract

INTRODUCTION: The problem of treatment of patients with chronic lower limb ischemia (CLLI) remains extremely important to date. This is first of all due to increase in the number of patients with chronic obliterating diseases of peripheral arteries, which hold one of the leading positions in the structure of morbidity and disability of the population over 60 years. The progression of the disease with development of critical CLLI leads to amputation of the limb within five years in a third of patients. The first line therapy for CLLI is endovascular interventions both stand-alone and with use of hybrid approach, especially in patients with critical CLLI. In many cases of multi-level, especially multifocal lesions of arterial vessels, the choice of revascularization tactics is not yet completely defined.

CONCLUSION: In recent years, there has been a trend of using endovascular revascularization technologies in continued stenosis and occlusions of the lower limb arteries. However, there is an essential need to study their long-term results, as well as to clarify the indications for stenting in critical CLLI.

Full Text

Restricted Access

About the authors

Alidzhon Dzh. Gaibov

Republican Scientific Center for Cardiovascular Surgery; Avicenna Tajik State Medical University

Email: gaibov_a.d@mail.ru
ORCID iD: 0000-0002-3889-368X
SPIN-code: 5152-0785

MD, Dr. Sci (Med.), Professor

Tajikistan, Dushanbe; Dushanbe

Okildzhon Nematzoda

Republican Scientific Center for Cardiovascular Surgery

Author for correspondence.
Email: rncssh@mail.ru
ORCID iD: 0000-0001-7602-7611
SPIN-code: 2408-9107

MD, Cand. Sci (Med)

Tajikistan, Dushanbe

Dzhamshed K. Rakhmonov

Republican Scientific Center for Cardiovascular Surgery

Email: amnmztj@gmail.com
ORCID iD: 0000-0003-2691-4065
Tajikistan, Dushanbe

Rustam K. Davlatov

Republican Scientific Center for Cardiovascular Surgery

Email: okil.sadriev@mail.ru
ORCID iD: 0000-0003-0397-3118
Tajikistan, Dushanbe

Egan L. Kalmykov

Clinic for Vascular and Endovascular Surgery

Email: egan0428@mail.ru
ORCID iD: 0000-0001-6784-2243
SPIN-code: 8623-8897

MD, Dr. Sci (Med.)

Germany, Brandenburg

References

  1. Conte MS, Bradbury AW, Kolh P, et al. Global vascular guidelines on the management of chronic limb-threatening ischemia. J Vasc Surg. 2019;69(6S):3S–125S.e40. doi: 10.1016/j.jvs.2019.02.016
  2. Natsional’nyye rekomendatsii po diagnostike i lecheniyu zabolevaniy arteriy nizhnikh konechnostey. Moscow; 2019. (In Russ).
  3. Pokrovskiy AV, Golovyuk AL. Sostoyaniye sosudistoy khirurgii v Rossiyskoy Federatsii v 2018 godu. Angiology and Vascular Surgery. 2019;25(2S):2–48. (In Russ).
  4. Gaibov AD, Kalmykov EL, Kamolov AN. Thrombosis of femoral vein stump after lower limb amputation. Cardiology and Cardiovascular Surgery. 2011;4(5):71–5. (In Russ).
  5. Aboyans V, Ricco J–B, Bartelink M–LEL, et al. Editor’s Choice — 2017 ESC Guidelines on the Diagnosis and Treatment of Peripheral Arterial Diseases, in collaboration with the European Society for Vascular Surgery (ESVS). Eur J Vasc Endovasc Surg. 2018;55(3):305–68. doi: 10.1016/j.ejvs.2017.07.018
  6. Alekyan BG, Zakaryan NV, Pankov AS. The modern state of endovascular treatment of atherosclerotic and diabetic lesions of lower limb arteries in the Russian Federation. Endovascular Surgery. 2016;3(4):5–12. (In Russ).
  7. Kalmykov EL, Suchkov IA, Niematzoda ON. On the problem of lumbar sympathectomy. Angiology and Vascular Surgery. 2017;23(4):181–5. (In Russ).
  8. Gaibov AD, Kalmykov EL, Kamolov AN. Low extremity amputation in treatment of chronic critical limb ischemia (data review). Cardiology and Cardiovascular Surgery. 2009;2(2):40–6. (In Russ).
  9. Mukhamadieva KhS, Gaibov AD, Baratov AK, et al. Place and value of endovascular and hybrid technologies in treatment of lower extremity peripheral artery disease. Avicenna Bulletin. 2018;20(1):103–12. (In Russ). doi: 10.25005/2074-0581-2018-20-1-103-112
  10. Kalmykov EL, Mzhavanadze ND, Suchkov IA. Review of the proceedings of the 68th International congress of the European society of cardiovascular and endovascular surgery (May 22–25, 2019). Angiology and Vascular Surgery. 2020;26(1):49–53. (In Russ).
  11. Cull DL, Langan EM, Gray BH, et al. Open versus endovascular intervention for critical limb ischemia: a population-based study. J Am Coll Surg. 2010;210(5):555–63. doi: 10.1016/j.jamcollsurg.2009.12.019
  12. Kudo T, Chandra FA, Kwun W–H, et al. Changing pattern of surgical revascularization for critical limb ischemia over 12 years: endovascular vs. open bypass surgery. J Vasc Surg. 2006;44(2):304–13. doi: 10.1016/j.jvs.2006.03.040
  13. Iida O, Takahara M, Kohsaka S, et al. Impact of Institutional Volume on Critical In-Hospital Complications Adjusted for Patient- and Limb-Related Characteristics: An Analysis of a Nationwide Japanese Registry of Endovascular Interventions for PAD. J Endovasc Ther. 2020;27(5):739–48. doi: 10.1177/1526602820923118
  14. Martini R. Trends of the treatment of Critical Limb Ischemia during the last two decades. Clin Hemorheol Microcirc. 2018;69(4):447–56. doi: 10.3233/CH-170352
  15. Schramm KM, DeWitt PE, Dybul S, et al. Recent Trends in Clinical Setting and Provider Specialty for Endovascular Peripheral Artery Disease Interventions for the Medicare Population. J Vasc Interv Radiol. 2020;31(4):614–21.e2. doi: 10.1016/j.jvir.2019.10.025
  16. Timaran CH, Prault TL, Stevens SL, et al. Iliac artery stenting versus surgical reconstruction for TASC (TransAtlantic Inter-Society Consensus) type B and type C iliac lesions. J Vasc Surg. 2003;38(2):272–8. doi: 10.1016/s0741-5214(03)00411-7
  17. Brountzos EN, Kelekis DA. Iliac artery angioplasty: technique and results. Acta Chir Belg. 2004;104(5):532–9. doi: 10.1080/ 00015458.2004.11679610
  18. Kolte D, Kennedy KF, Shishehbor MH, et al. Thirty-Day Readmissions After Endovascular or Surgical Therapy for Critical Limb Ischemia: Analysis of the 2013 to 2014 Nationwide Readmissions Databases. Circulation. 2017;136(2):167–76. doi: 10.1161/CIRCULATIONAHA.117.027625
  19. Tran K, Ullery BW, Kret MR, et al. Real-World Performance of Paclitaxel Drug-Eluting Bare Metal Stenting (Zilver PTX) for the Treatment of Femoropopliteal Occlusive Disease. Ann Vasc Surg. 2017;38:90–8. doi: 10.1016/j.avsg.2016.08.006
  20. Goode SD, Keltie K, Burn J, et al. Effect of procedure volume on outcomes after iliac artery angioplasty and stenting. Br J Surg. 2013;100(9):1189–96. doi: 10.1002/bjs.9199
  21. Miller C, Frood R, See TC, et al. British Society of Interventional Radiology Iliac Angioplasty and Stent Registry: fourth report on an additional 8,294 procedures. Clin Radiol. 2019;74(6):429–34. doi: 10.1016/j.crad.2019.01.026
  22. Bekken J, Jongsma H, Ayez N, et al. Angioplasty versus stenting for iliac artery lesions. Cochrane Database Syst Rev. 2015;(5):CD007561. doi: 10.1002/14651858.CD007561.pub2
  23. Jongsma H, Bekken J, Ayez N, et al. Angioplasty versus stenting for iliac artery lesions. Cochrane Database Syst Rev. 2020;12(12):CD007561. doi: 10.1002/14651858.CD007561.pub3
  24. Piffaretti G, Fargion AT, Dorigo W, et al. Endovascular Reconstruction for Total Aorto-Iliac Occlusion. J Endovasc Ther. 2022;29(4):565–75. doi: 10.1177/15266028211059908
  25. Borghese O, Ferrer C, Coscarella C, et al. Two-year single centre results with covered endovascular reconstruction of aortic bifurcation (CERAB) in the treatment of extensive aorto-iliac occlusive disease. Vascular. 2022;30(3):500–8. doi: 10.1177/17085381211018336
  26. Piffaretti G, Fargion AT, Dorigo W, et al. Outcomes From the Multicenter Italian Registry on Primary Endovascular Treatment of Aortoiliac Occlusive Disease. J Endovasc Ther. 2019;26(5):623–32. doi: 10.1177/1526602819863081
  27. Squizzato F, Piazza M, Pulli R, et al. Covered versus bare metal kissing stents for reconstruction of the aortic bifurcation in the ILIACS registry. J Vasc Surg. 2021;73(6):1980–90.e4. doi: 10.1016/j.jvs.2020.10.066
  28. Starodubtsev V, Mitrofanov V, Ignatenko P, et al. Editor's Choice — Hybrid vs. Open Surgical Reconstruction for Iliofemoral Occlusive Disease: A Prospective Randomised Trial. Eur J Vasc Endovasc Surg. 2022;63(4):557–65. doi: 10.1016/j.ejvs.2022.02.002
  29. Janczak D, Malinowski M, Bąkowski W, et al. Comparison of the Incidence of Complications and Secondary Surgical Interventions Necessary in Patients with Chronic Lower Limb Ischemia Treated by Both Open and Endovascular Surgeries. Ann Thorac Cardiovasc Surg. 2017;23(3):135–40. doi: 10.5761/atcs.oa.16-00282
  30. Ko Y–G, Shin S, Kim KJ, et al. Efficacy of stent-supported subintimal angioplasty in the treatment of long iliac artery occlusions. J Vasc Surg. 2011;54(1):116–22. doi: 10.1016/j.jvs.2010.11.127
  31. Minko P, Katoh M, Opitz A, et al. Subintimal revascularization of chronic iliac artery occlusions using a reentry-catheter. Rofo. 2011; 183(6):549–53. doi: 10.1055/s-0031-1273345
  32. Timaran CH, Stevens SL, Freeman MB, et al. External iliac and common iliac artery angioplasty and stenting in men and women. J Vasc Surg. 2001;34(3):440–6. doi: 10.1067/mva.2001.117148
  33. Ebaugh JL, Gupta N, Raffetto JD. Single-incision external iliac artery endarterectomy and patch angioplasty. Ann Vasc Surg. 2011;25(8):1165–9. doi: 10.1016/j.avsg.2011.05.032
  34. Gaibov AD, Muhammadieva KhS, Kalmikov EL, et al. Radial diagnostics capabilities of occlusive-stenotic lesions of the lower limb arteries. Bulletin of the Academy of Medical Sciences of Tajikistan. 2016;3:3–11. (In Russ).
  35. Zhuang J–M, Li X, Li T–R, et al. Comparison of the clinical efficacy of endovascular reconstruction versus bypass surgery for transatlantic inter-society consensus II C/D femoropopliteal artery lesion resulted from arteriosclerosis obliterans. Beijing Da Xue Xue Bao. Yi Xue Ban. 2015;47(6):957–61.
  36. Wang B, Wang G, Yang R. A comparison for the patency rate of TASC II C/D femoropopliteal arterial disease between endovascular treatment and arterial bypass therapy. Zhonghua Yi Xue Za Zhi. 2015;95(14):1100–3.
  37. Veraldi GF, Mezzetto L, Macrì M, et al. Comparison of Endovascular Versus Bypass Surgery in Femoropopliteal TASC II D Lesions: A Single-Center Study. Ann Vasc Surg. 2018;47:179–87. doi: 10.1016/j.avsg.2017.09.008
  38. Diamantopoulos A, Katsanos K. Atherectomy of the femoropopliteal artery: a systematic review and meta-analysis of randomized controlled trials. J Cardiovasc Surg (Torino). 2014;55(5):655–65.
  39. McQuade K, Gable D, Hohman S, et al. Randomized comparison of ePTFE/nitinol self-expanding stent graft vs prosthetic femoral-popliteal bypass in the treatment of superficial femoral artery occlusive disease. J Vasc Surg. 2009;49(1):109–16.E9. doi: 10.1016/j.jvs.2008.08.041
  40. Zhuang J–M, Li X, Li T–R, et al. Percutaneous transluminal angioplasty versus stent implantation for treatment of femoral and popliteal artery lesion resulted from arteriosclerosis obliterans. Beijing Da Xue Xue Bao. Yi Xue Ban. 2016;48(1):160–5.
  41. Ben Hammamia M, Ben Mrad M, Derbel B, et al. Femoropopliteal angioplasty: Short- and mid-term results. J Med Vasc. 2017;42(4):204–2. doi: 10.1016/j.jdmv.2017.04.001
  42. Mehrotra S, Paramasivam G, Mishra S. Paclitaxel-Coated Balloon for Femoropopliteal Artery Disease. Curr Cardiol Rep. 2017;19:10. doi: 10.1007/s11886-017-0823-4
  43. Kinstner CM, Lammer J, Willfort–Ehringer A, et al. Paclitaxel-Eluting Balloon Versus Standard Balloon Angioplasty in In-Stent Restenosis of the Superficial Femoral and Proximal Popliteal Artery: 1-Year Results of the PACUBA Trial. JACC Cardiovasc Interv. 2016;9(13):1386–92. doi: 10.1016/j.jcin.2016.04.012
  44. Liistro F, Grotti S, Porto I, et al. Drug-eluting balloon in peripheral intervention for the superficial femoral artery: the DEBATE-SFA randomized trial (drug eluting balloon in peripheral intervention for the superficial femoral artery). JACC Cardiovasc Interv. 2013;6(12):1295–302. doi: 10.1016/j.jcin.2013.07.010
  45. Gray WA, Cardenas JA, Brodmann M, et al. Treating Post-Angioplasty Dissection in the Femoropopliteal Arteries Using the Tack Endovascular System: 12-Month Results From the TOBA II Study. JACC Cardiovasc Interv. 2019;12(23):2375–84. doi: 10.1016/j.jcin.2019.08.005
  46. Sayed A, Taha A, Elkholy M, et al. Tibial angioplasty in diabetic patients: should all vessels be treated? Int Angiol. 2012;31(3):239–44.
  47. Baumann F, Fust J, Engelberger RP, et al. Early recoil after balloon angioplasty of tibial artery obstructions in patients with critical limb ischemia. J Endovasc Ther. 2014;21(1):44–51. doi: 10.1583/13-4486MR.1
  48. Hsu CC–T, Kwan GN, Singh D, et al. Angioplasty versus stenting for infrapopliteal arterial lesions in chronic limb-threatening ischaemia. Cochrane Database Syst Rev. 2018;12(12):CD009195. doi: 10.1002/14651858.CD009195.pub2
  49. Werneck CCF, Lindsay TF. Tibial angioplasty for limb salvage in high-risk patients and cost analysis. Ann Vasc Surg. 2009;23(5):554–9. doi: 10.1016/j.avsg.2009.05.007

Supplementary files

Supplementary Files
Action
1. JATS XML
Download

Copyright (c) 2023 Eco-Vector

License URL: https://eco-vector.com/for_authors.php#07

Media Registry Entry of the Federal Service for Supervision of Communications, Information Technology and Mass Communications (Roskomnadzor) PI No. FS77-76803 dated September 24, 2019.



This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies